Table 1.
Primary endpoint | Cardiovascular mortality | Ischemia driven revascularization | Ischemia driven revascularization + resuscitation | Myocardial infarction | Stroke | Death | Hs CRP | |
---|---|---|---|---|---|---|---|---|
Nidorf (11) | + | + | + | + | + | + | ||
Shah (16) | + | + | + | + | ||||
Tong (12) | + | + | + | + | + | + | ||
Tardif (10) | + | + | + | + | + | + | + | |
Nidorf (17) | + | + | + | + | + | + | + | |
Deftereos (18) | + | + | ||||||
Deftereos (19) | + | + | + | + | ||||
Hennessy (20) | + | + | + | |||||
Akodad (21) | + | |||||||
Raju (22) | + | + | ||||||
O'Keefe (23) | + | |||||||
Kajikawa (7) | + | |||||||
Vaidya (8) | + | |||||||
Nidorf (24) | + |
Hs CRP, high sensitive C-reactive protein.